Milestone 2.D
Create programs in basic, translational and clinical research aimed at comprehensive understanding of the impact of sex differences on the trajectories of brain aging and disease, phenotypes of AD and ADRD risk and responsiveness to treatment.
Success Criteria
- Launch at least 12 new projects exploring the impact of sex differences on the trajectories of brain aging and disease, phenotypes of risk for AD and related dementias and responsiveness to treatment.
- Research Implementation Area
- Research on Disease Mechanisms
- Timeline
- 2016–2023
- Status
- Achieved
Accomplishments/Implementation Activities
Funding Initiatives
- PAR-17-033: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
- RFA-AG-21-029: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
- NOT-AG-20-038: Sex and Gender Differences in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)